Injectable Platelet-, Leukocyte-, and Fibrin-Rich Plasma in the Management of Androgenetic Alopecia

    July 2018 in “ Dermatologic Surgery
    Giovanni Schiavone, Andrea Paradisi, Francesco Ricci, Damiano Abeni
    New to Platelet-Rich Plasma? There is a guide in the encyclopedia. Read the guide →
    Image
    Studysummary In this study, iL-PRF injections produced significantly better clinical scores for androgenetic alopecia patients compared to controls, especially in those with more severe baseline conditions.
    Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
    The study investigated the effectiveness of injectable platelet-, leukocyte-, and fibrin-rich plasma (iL-PRF) in managing androgenetic alopecia (AGA). The results showed that iL-PRF treatment led to significant improvement in hair growth compared to the control group, regardless of the severity of the condition and sex. The study suggests that iL-PRF could be a promising treatment option for AGA.
    Discuss this study in the Community →

    Research cited in this study

    19 / 19 results